BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18771584)

  • 1. Var2CSA DBL6-epsilon domain expressed in HEK293 induces limited cross-reactive and blocking antibodies to CSA binding parasites.
    Fernandez P; Viebig NK; Dechavanne S; Lépolard C; Gysin J; Scherf A; Gamain B
    Malar J; 2008 Sep; 7():170. PubMed ID: 18771584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strain-transcendent immune response to recombinant Var2CSA DBL5-ε domain block P. falciparum adhesion to placenta-derived BeWo cells under flow conditions.
    Fernandez P; Petres S; Mécheri S; Gysin J; Scherf A
    PLoS One; 2010 Sep; 5(9):e12558. PubMed ID: 20838433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of strain-transcendent antibodies to placental-type isolates with VAR2CSA DBL3 or DBL5 recombinant proteins.
    Avril M; Cartwright MM; Hathaway MJ; Smith JD
    Malar J; 2011 Feb; 10():36. PubMed ID: 21314945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to Escherichia coli-expressed C-terminal domains of Plasmodium falciparum variant surface antigen 2-chondroitin sulfate A (VAR2CSA) inhibit binding of CSA-adherent parasites to placental tissue.
    Saveria T; Oleinikov AV; Wiliamson K; Chaturvedi R; Lograsso J; Keitany GJ; Fried M; Duffy P
    Infect Immun; 2013 Apr; 81(4):1031-9. PubMed ID: 23319559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for globally shared, cross-reacting polymorphic epitopes in the pregnancy-associated malaria vaccine candidate VAR2CSA.
    Avril M; Kulasekara BR; Gose SO; Rowe C; Dahlbäck M; Duffy PE; Fried M; Salanti A; Misher L; Narum DL; Smith JD
    Infect Immun; 2008 Apr; 76(4):1791-800. PubMed ID: 18250177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies.
    Salanti A; Resende M; Ditlev SB; Pinto VV; Dahlbäck M; Andersen G; Manczak T; Theander TG; Nielsen MA
    Malar J; 2010 Jan; 9():11. PubMed ID: 20064234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates.
    Avril M; Hathaway MJ; Srivastava A; Dechavanne S; Hommel M; Beeson JG; Smith JD; Gamain B
    PLoS One; 2011 Feb; 6(2):e16622. PubMed ID: 21326877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VAR2CSA domains expressed in Escherichia coli induce cross-reactive antibodies to native protein.
    Oleinikov AV; Francis SE; Dorfman JR; Rossnagle E; Balcaitis S; Getz T; Avril M; Gose S; Smith JD; Fried M; Duffy PE
    J Infect Dis; 2008 Apr; 197(8):1119-23. PubMed ID: 18462161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of adhesion-inhibitory antibodies against placental Plasmodium falciparum parasites by using single domains of VAR2CSA.
    Nielsen MA; Pinto VV; Resende M; Dahlbäck M; Ditlev SB; Theander TG; Salanti A
    Infect Immun; 2009 Jun; 77(6):2482-7. PubMed ID: 19307213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to Plasmodium falciparum Placental Malaria.
    Doritchamou JY; Herrera R; Aebig JA; Morrison R; Nguyen V; Reiter K; Shimp RL; MacDonald NJ; Narum DL; Fried M; Duffy PE
    J Infect Dis; 2016 Aug; 214(4):577-86. PubMed ID: 27190180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with VAR2CSA-DBL5 recombinant protein elicits broadly cross-reactive antibodies to placental Plasmodium falciparum-infected erythrocytes.
    Avril M; Cartwright MM; Hathaway MJ; Hommel M; Elliott SR; Williamson K; Narum DL; Duffy PE; Fried M; Beeson JG; Smith JD
    Infect Immun; 2010 May; 78(5):2248-56. PubMed ID: 20194590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating antibody functional activity and strain-specificity of vaccine candidates for malaria in pregnancy using in vitro phagocytosis assays.
    Hommel M; Chan JA; Umbers AJ; Langer C; Rogerson SJ; Smith JD; Beeson JG
    Parasit Vectors; 2018 Jan; 11(1):69. PubMed ID: 29378634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites.
    Costa FT; Fusaï T; Parzy D; Sterkers Y; Torrentino M; Douki JB; Traoré B; Petres S; Scherf A; Gysin J
    J Infect Dis; 2003 Jul; 188(1):153-64. PubMed ID: 12825185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates.
    Doritchamou JYA; Renn JP; Jenkins B; Mahamar A; Dicko A; Fried M; Duffy PE
    Elife; 2022 Feb; 11():. PubMed ID: 35103596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of Duffy binding-like domains that bind chondroitin sulfate A and protection against pregnancy-associated malaria.
    Bir N; Yazdani SS; Avril M; Layez C; Gysin J; Chitnis CE
    Infect Immun; 2006 Oct; 74(10):5955-63. PubMed ID: 16988275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Id1-DBL2X of VAR2CSA as a key domain inducing highly inhibitory and cross-reactive antibodies.
    Bordbar B; Tuikue-Ndam N; Bigey P; Doritchamou J; Scherman D; Deloron P
    Vaccine; 2012 Feb; 30(7):1343-8. PubMed ID: 22226864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing a VAR2CSA-based vaccine to prevent placental malaria.
    Fried M; Duffy PE
    Vaccine; 2015 Dec; 33(52):7483-8. PubMed ID: 26469717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multilaboratory approach to preclinical evaluation of vaccine immunogens for placental malaria.
    Fried M; Avril M; Chaturvedi R; Fernandez P; Lograsso J; Narum D; Nielsen MA; Oleinikov AV; Resende M; Salanti A; Saveria T; Williamson K; Dicko A; Scherf A; Smith JD; Theander TG; Duffy PE
    Infect Immun; 2013 Feb; 81(2):487-95. PubMed ID: 23208604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA.
    Pinto VV; Ditlev SB; Jensen KE; Resende M; Dahlbäck M; Andersen G; Andersen P; Theander TG; Salanti A; Nielsen MA
    PLoS One; 2011 Mar; 6(3):e17942. PubMed ID: 21464946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of glycosaminoglycan binding regions in the Plasmodium falciparum encoded placental sequestration ligand, VAR2CSA.
    Resende M; Nielsen MA; Dahlbäck M; Ditlev SB; Andersen P; Sander AF; Ndam NT; Theander TG; Salanti A
    Malar J; 2008 Jun; 7():104. PubMed ID: 18534039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.